Nettet5. apr. 2008 · The absolute differences in haematoma volume between the treatment groups might also have been smaller than in the rFVIIa trials because the mean … Nettet30. mar. 2024 · In the ongoing InterAACT trial, toxicity and QoL will be used to make the selection if the response rates are equal. However, if response rates are very similar but not equal, the treatment with the highest observed rate will be selected even if the difference might be due to chance.
InterAACT: A multicentre open label randomised phase II …
Nettet6. jun. 2024 · InterAACT was an international multicenter randomized phase II trial which compared the efficacy and safety of carboplatin (AUC 5, day 1) plus paclitaxel (80 mg/m 2, days 1, 8, and 15) every 28 days, vs. cisplatin (60 mg/m 2, day 1) plus 5-FU (1,000 mg/m 2, days 1–4) every 21 days, for 24 weeks, in the first-line systemic therapy of … Nettet13. nov. 2014 · Interpretation and Implementation of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT II). J Vasc Interv Neurol. 2014; 7:34–40. Google Scholar; 23. Bath PMW, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012; … rivertown alf blountstown fl
Implications of INTERACT2 and Other Clinical Trials Stroke
NettetWhen anal cancer spreads to another part of the body or comes back after treatment, doctors often treat it with chemotherapy.When this trial was done, they often used a combination of 2 chemotherapy drugs called cisplatin and 5-fluorouracil (5FU).. At the time, doctors used the combination of carboplatin and paclitaxel (Taxol) to treat other types … Nettet15. jul. 2024 · Brief Summary: This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy. Study Design Go to Resource links provided by the National Library of Medicine Nettet1. feb. 2015 · InterAACT aims to provide the first randomised evidence for the treatment of ILR and metastatic SCCA, to identify the optimal chemotherapy backbone to combine with targeted agents in future... river town adventures